CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Sodium-Glucose Co-Transporter 2 Inhibitors and Insights from Biomarker Measurement in Heart Failure Patients Modifiable lifestyle factors and heart failure: A Mendelian randomization study Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial The multiple causes and treatments of heart failure: focus on genetic and molecular mechanisms and non-pharmacological interventions A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial

Guideline2017 Aug 8;70(6):776-803

JOURNAL:J Am Coll Cardiol. Article Link

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

Yancy CW, Jessup M, Bozkurt B et al. Keywords: ACC/AHA Clinical Practice Guidelines; angioedema; angiotensin receptor blockers; angiotensin receptor-neprilysin inhibitor; angiotensin-converting enzyme inhibitors; beta blockers; ferric carboxymaltose; focused update; heart failure; hypertension; iron deficiency; ivabradine; natriuretic peptide biomarker; natriuretic peptides; sleep apnea

Full Text PDF